| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |